Invectys Therapeutics Funding: $58M Raised, Series A (2018)
Invectys Therapeutics is based in Houston. It has raised $58M in total funding. Latest round: Series A. Backed by Historical shareholders.
Invectys Therapeutics funding overview
Invectys Therapeutics is based in Houston. Invectys Therapeutics has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2018. The round record for Invectys Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Historical shareholders.
Invectys Therapeutics at a glance
Total raised
$58M
Latest round
Series A
Latest round date
October 2018
Headquarters
Houston
Notable investors
Historical shareholders
Frequently asked about Invectys Therapeutics funding
How much has Invectys Therapeutics raised?
Invectys Therapeutics has raised $58M in total disclosed funding across the rounds on record.
Who has invested in Invectys Therapeutics?
Historical shareholders are named among the investors backing Invectys Therapeutics.
What was the latest Invectys Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2018.
Where is Invectys Therapeutics based?
Invectys Therapeutics is based in Houston.
When did Invectys Therapeutics last raise?
The last disclosed Invectys Therapeutics round closed in October 2018 at Series A.
We update the Invectys Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Houston and their backers are listed below.
